By Alex Konrad | Forbes
Venture capitalist Mike Lynn was cycling in the Berkeley Hills in 2014 when the cars started passing him at high speed. As they whizzed by on the winding roads in California’s Bay Area, they left behind mementos: the distinct smell of marijuana.
Lynn’s day job was to invest in startups, but he was a doctor by training and a reserve police officer, too. He started seeing examples of drivers showing up at hospitals injured who’d clearly been using cannabis before their accidents. The business and public safety parts of his brain conspired together. Lynn quit his job at Adams Street Partners to work on what he hoped would be the industry’s first breathalyzer for THC.
Three years later, Lynn’s startup Hound Labs has scored millions from one of Silicon Valley’s most prestigious venture capital firms as Lynn says the company’s moved into live field trials ahead of a late 2017 launch.
